- Home
- QNCX vs PAVS Comparison
QNCX vs PAVS Comparison
Compare QNCX & PAVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QNCX | PAVS |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 1.5M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | QNCX | PAVS |
|---|---|---|
| Price | $2.81 | $2.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | 698.3K | ★ 6.6M |
| Earning Date | 11-12-2025 | 08-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,416,127.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18037.91 |
| 52 Week Low | $0.72 | $1.38 |
| 52 Week High | $4.55 | $150.00 |
Technical Indicators
Market Signals| Indicator | QNCX | PAVS |
|---|---|---|
| Relative Strength Index (RSI) | 38.83 | 66.54 |
| Support Level | $3.18 | $1.60 |
| Resistance Level | $3.38 | $2.49 |
| Average True Range (ATR) | 0.27 | 0.42 |
| MACD | -0.17 | 0.09 |
| Stochastic Oscillator | 6.51 | 58.57 |
Price Performance
Historical ComparisonAbout QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About PAVS Paranovus Entertainment Technology Ltd.
Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.